Kârlılık
Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
IBIO
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-4650.5%
—
Net Profit Margin (Net Kâr Marjı)
-4594.2%
-1601.1%
ROA
-70.8%
-68.1%
ROE
-101.5%
-111.7%
Finansal Sağlık
Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
IBIO
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.1
0.0
Current Ratio (Cari Oran)
1.6
4.1
Quick Ratio (Cari Oran)
1.4
—
Büyüme
Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
IBIO
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
77.8%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-40.3%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
-24.6%
—
Hisse Başı Metrikler
Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü
Metrik
5 Yıllık trend
IBIO
Akran Ortalaması
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))
$-1.75
—
Sermaye Verimliliği
Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
IBIO
Akran Ortalaması
IBIO Analist Uzlaşması
Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL14 analist
Güçlü Al
428,6%
Al
964,3%
Tut
17,1%
Sat
00,0%
Güçlü Sat
00,0%
12 Aylık Fiyat Hedefi
8 analist
· 2026-08-13
Medyan$5.00
Ortalama$5.40
← Tüm hedeflerin altında
$1.46
Düşük$4.20
Yüksek$7.00
Medyan hedef$5.00
+243,6%
Ortalama hedef$5.40
+271,1%
Kazanç Geçmişi
EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.05%
Sonraki Rapor
Eyl 03, 2026
Dönem
EPS Gerçek
EPS Tahmin
Sürpriz
31 Mart 2026
$-0.06
$-0.06
0.00%
31 Aralık 2025
$-0.09
$-0.08
-0.01%
30 Eylül 2025
$-0.11
$-0.10
-0.01%
30 Haziran 2025
$-0.49
$-0.37
-0.12%
31 Mart 2025
$-0.49
$-0.37
-0.12%
Akran karşılaştırması (GICS alt sektörü)
Anahtar metrikler sektördeki benzerlerine karşı
Hisse Sembolü
Piyasa Değeri
P/E
Gelir YoY
Net Kar Marjı
ROE
Brüt Kar Marjı
IBIO
$15M
-0.4
77.8%
-4594.2%
-101.5%
—
FRMM
—
—
—
-6881.3%
-368.1%
—
ANVS
$94M
-2.5
—
—
-164.0%
—
CYPH
$97M
16.6
—
—
6.1%
—
NMAD
—
—
—
—
—
—
RNTX
—
-0.6
—
—
—
—
DWTX
$124M
-0.6
123.6%
—
-83.8%
—
CRDF
$192M
-4.1
-13.2%
-7732.0%
-88.2%
—
SPRO
$131M
15.5
39.2%
12.8%
18.7%
—
GOSS
$724M
-4.1
-57.7%
-351.5%
201.8%
—
Tüm Temeller
Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu17
IBIO için Yıllık Gelir Tablosu verileri
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue
$400.0K
$225.0K
$0
$2M
$2M
$2M
$2M
$444.0K
$394.0K
$948.0K
$2M
$205.0K
Cost of Revenue
·
·
·
$216.0K
$1M
$703.0K
·
·
·
·
·
·
Gross Profit
·
·
·
$2M
$909.0K
$935.0K
·
·
·
·
·
·
R&D Expense
$8M
$5M
$10M
$10M
$10M
$4M
$5M
$4M
$4M
$3M
$3M
$2M
SG&A Expense
$11M
$12M
$19M
$22M
$22M
$11M
$12M
$11M
$11M
$8M
$5M
$4M
Operating Expenses
$19M
$17M
$29M
$32M
$32M
$15M
$18M
$15M
$15M
$11M
$9M
$4M
Operating Income
$-19M
$-17M
$-29M
$-30M
$-31M
$-14M
$-16M
$-14M
$-14M
$-10M
$-7M
$-4M
Interest Expense
·
·
$83.0K
$1M
$2M
$2M
$2M
$2M
$2M
$807.0K
$0
$0
Interest Income
$437.0K
$363.0K
$213.0K
$177.0K
$140.0K
$15.0K
$75.0K
$15.0K
$39.0K
$22.0K
$9.0K
$8.0K
Other Non-op
$225.0K
$1M
$32.0K
$184.0K
$8M
$-2M
$-2M
$-2M
$-2M
$-764.0K
$41.0K
$3.0K
Income Tax
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Net Income
$-18M
$-25M
$-65M
$-50M
$-23M
$-16M
$-18M
$-16M
$-15M
$-10M
$-7M
$-4M
EPS (Basic)
$-1.75
$-6.50
$-106.19
$-5.78
$-3.00
·
·
·
·
·
·
·
EPS (Diluted)
$-1.75
$-6.50
$-106.19
$-5.78
$-3.00
·
·
·
·
·
·
·
Shares (Basic)
10,499,000
3,831,000
612,000
8,721,000
7,825,000
·
·
·
·
·
·
·
Shares (Diluted)
10,499,000
3,831,000
612,000
8,721,000
7,825,000
·
·
·
·
·
·
·
EBITDA
$-19M
$-17M
$-29M
$-50M
$-31M
·
$-16M
$-14M
$-14M
$-10M
$-7M
·
Bilanço24
IBIO için Yıllık Bilanço verileri
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Cash & Equivalents
$9M
$14M
$4M
$23M
$77M
$55M
$4M
$4M
$16M
$16M
$9M
$4M
Receivables
·
$0
$0
$1M
$426.0K
$75.0K
$97.0K
$75.0K
$175.0K
$484.0K
$445.0K
$205.0K
Inventory
·
$0
$0
$4M
$27.0K
·
·
·
·
·
·
·
Prepaid Expense
$1M
$749.0K
$664.0K
$2M
$2M
$214.0K
$290.0K
$276.0K
$283.0K
$264.0K
$182.0K
$118.0K
Other Current Assets
·
·
·
·
·
·
·
·
·
·
$17.0K
$8.0K
Current Assets
$10M
$16M
$26M
$45M
$105M
$62M
$5M
$16M
$9M
$24M
$10M
$4M
PP&E (Net)
$3M
$4M
$4M
$1M
$9M
$4M
$24M
$25M
$26M
$26M
$13.0K
$6.0K
PP&E (Gross)
$5M
$5M
$5M
$1M
$10M
$4M
$29M
$28M
$27M
$26M
$40.0K
·
Accum. Depreciation
$1M
$1M
$400.0K
$0
$1M
$753.0K
$5M
$3M
$2M
$605.0K
$27.0K
·
Intangibles
$7M
$5M
$5M
$5M
$952.0K
$1M
$1M
$2M
$2M
$2M
$2M
$3M
Total Assets
$23M
$29M
$41M
$99M
$147M
$94M
$31M
$43M
$36M
$52M
$12M
$6M
Accounts Payable
$2M
$358.0K
$2M
$4M
$2M
$2M
$1M
$790.0K
$749.0K
$1M
$1M
$297.0K
Accrued Liabilities
$1M
$2M
$5M
$4M
$3M
$1M
$965.0K
$1M
$924.0K
$920.0K
$159.0K
$98.0K
Short-term Debt
$766.0K
$218.0K
$13M
$22M
$600.0K
$261.0K
$0
·
·
·
·
·
Current Liabilities
$6M
$4M
$22M
$30M
$7M
$5M
$3M
$2M
$2M
$2M
$1M
$395.0K
Capital Leases
$2M
$3M
$3M
$4M
$0
$0
$25M
$25M
$25M
$25M
$0
·
Total Liabilities
$8M
$7M
$26M
$36M
$38M
$38M
$28M
$27M
$27M
$28M
$1M
$395.0K
Total Debt
$766.0K
$218.0K
$13M
$22M
$600.0K
·
·
·
·
·
·
·
Common Stock
$19.0K
$9.0K
$1.0K
$9.0K
$9.0K
$140.0K
$20.0K
$16.0K
$9.0K
$89.0K
$77.0K
$66.0K
Retained Earnings
$-332M
$-314M
$-289M
$-224M
$-174M
$-150M
$-106M
$-88M
$-72M
$-58M
$-48M
$-41M
AOCI
·
·
·
$-213.0K
$-63.0K
$-33.0K
$-31.0K
$-30.0K
$-29.0K
$-29.0K
$-25.0K
$0
Stockholders' Equity
$15M
$21M
$15M
$63M
$109M
$57M
$2M
$16M
$9M
$10M
$11M
$6M
Liabilities + Equity
$23M
$29M
$41M
$99M
$147M
$94M
$31M
$43M
$36M
$52M
$12M
$6M
Shares Outstanding
19,349,201
8,623,676
1,015,505
8,727,158
8,714,924
140,071,110
20,152,458
16,040,126
8,911,851
89,109,410
77,205,410
65,642,095
Nakit Akışı12
IBIO için Yıllık Nakit Akışı verileri
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
D&A
·
·
·
·
·
·
$179.0K
·
·
·
·
·
Stock-based Comp
$2M
$2M
$4M
$4M
$2M
$388.0K
$241.0K
$770.0K
$1M
$1M
$914.0K
$1M
Deferred Tax
$-9M
$-5M
$-13M
·
·
·
·
·
·
·
·
·
Amort. of Intangibles
$20.0K
$20.0K
$126.0K
$401.0K
$291.0K
$298.0K
$322.0K
$341.0K
$350.0K
$363.0K
$358.0K
$358.0K
Operating Cash Flow
$-15M
$-19M
$-30M
$-37M
$-30M
$-13M
$-14M
$-13M
$-13M
$-8M
$-5M
$-4M
CapEx
$16.0K
$210.0K
$6M
$7M
$5M
$1M
$920.0K
$934.0K
$1M
$68.0K
$13.0K
$4.0K
Investing Cash Flow
$742.0K
$906.0K
$7M
$-5M
$-26M
$-1M
$-990.0K
$-1M
$-2M
·
·
·
Stock Issued
$4M
$26M
$11M
·
·
·
·
·
$0
$6M
$10M
$480.0K
Net Stock Activity
$4M
$26M
·
·
·
·
·
·
$0
$6M
$10M
·
Financing Cash Flow
$9M
$24M
$2M
$-6M
$79M
$65M
$3M
$22M
$-170.0K
·
·
·
Net Change in Cash
$-6M
$7M
$-21M
$-49M
$22M
$51M
$-12M
$8M
$-15M
$14M
$6M
$-824.0K
Free Cash Flow
$-15M
$-19M
$-36M
$-45M
$-35M
·
$-15M
$-14M
$-14M
$-8M
$-5M
·
Kârlılık6
IBIO için Yıllık Kârlılık verileri
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Gross Margin
·
·
·
90.9%
38.3%
·
·
·
·
·
·
·
Operating Margin
-4650.5%
-7392.9%
·
-2085.2%
-1312.1%
·
-782.4%
-3204.3%
-3622.8%
-1043.6%
-360.1%
·
Net Margin
-4594.2%
-11069.8%
·
-2110.9%
-978.8%
·
-871.8%
-3627.2%
-3688.3%
-1030.0%
-357.9%
·
EBITDA Margin
-4650.5%
-7392.9%
·
-2085.2%
-1312.1%
·
-782.4%
-3204.3%
-3622.8%
-1043.6%
-360.1%
·
ROA
-70.8%
-71.2%
-92.5%
-40.8%
-16.0%
·
-53.1%
-43.5%
-37.9%
-19.1%
-69.8%
·
ROE
-101.5%
-135.7%
-164.9%
-58.5%
-28.1%
·
-188.9%
-128.4%
-154.2%
-92.2%
-76.5%
·
Likidite ve Solventlik4
IBIO için Yıllık Likidite ve Solventlik verileri
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Current Ratio
1.6
4.1
1.2
1.5
15.7
·
1.4
8.0
4.3
10.4
·
·
Quick Ratio
1.4
3.7
0.2
0.8
11.7
·
1.3
7.9
4.1
10.3
·
·
Debt / Equity
0.1
0.0
0.8
0.3
0.0
·
·
·
·
·
·
·
Interest Coverage
·
·
-353.5
-35.2
-12.7
·
-8.3
-7.4
-7.4
-12.3
·
·
Verimlilik3
IBIO için Yıllık Verimlilik verileri
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Asset Turnover
0.0
0.0
0.0
0.0
0.0
·
0.1
0.0
0.0
0.0
0.2
·
Inventory Turnover
·
·
·
0.1
·
·
·
·
·
·
·
·
Receivables Turnover
·
·
·
3.3
9.5
·
23.5
3.6
1.2
2.0
5.7
·
Hisse Başına5
IBIO için Yıllık Hisse Başına verileri
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Book Value / Share
$0.77
$2.47
$0.76
$7.27
$0.50
·
$0.12
$1.01
$0.10
$0.11
$0.15
·
Revenue / Share
$0.04
$0.06
$0.00
$0.27
·
·
·
·
·
·
·
·
Cash Flow / Share
$-1.46
$-4.84
$-2.49
$-4.30
·
·
·
·
·
·
·
·
Cash / Share
$0.44
$1.65
$0.21
$2.60
$0.36
·
$0.22
$0.99
$0.09
$0.26
$0.12
·
EPS (TTM)
$-1.75
$-6.50
$-106.19
$-5.78
$-3.00
·
·
·
·
·
·
·
Büyüme Oranları3
IBIO için Yıllık Büyüme Oranları verileri
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue YoY
77.8%
·
·
-20.5%
44.8%
·
·
·
·
·
·
·
Revenue CAGR 3Y
-40.3%
-54.4%
·
·
·
·
·
·
·
·
·
·
Revenue CAGR 5Y
-24.6%
·
·
·
·
·
·
·
·
·
·
·
Değerleme (TTM)14
IBIO için Yıllık Değerleme (TTM) verileri
Metrik
Eğilim
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue TTM
$400.0K
$225.0K
$0
$2M
$2M
$2M
$2M
$444.0K
$394.0K
$948.0K
$2M
$205.0K
Net Income TTM
$-18M
$-25M
$-65M
$-50M
$-23M
$-16M
$-18M
$-16M
$-15M
$-10M
$-7M
$-4M
Market Cap
$15M
$18M
$248M
$1.13B
$164.49B
·
$7.15B
$7.22B
$173.78B
$320.79B
$366.73B
·
Enterprise Value
$7M
$4M
$256M
$1.13B
$164.42B
·
·
·
·
·
·
·
P/E
-0.4
-0.3
-0.1
-22.5
-251.7
·
·
·
·
·
·
·
P/S
36.8
80.9
·
602.2
69377.6
·
3545.2
16256.9
441068.8
338390.2
198123.0
·
P/B
1.0
0.9
16.1
17.9
1514.9
·
2904.6
446.5
19495.3
32282.8
32653.0
·
P / Tangible Book
1.8
1.1
24.8
19.3
1528.3
2802.7
·
·
·
·
·
·
P / Cash Flow
-1.0
-1.0
-8.1
-30.3
-5471.5
·
-511.9
-535.5
-13202.2
-39741.6
-77613.9
·
P / FCF
-1.0
-1.0
-6.8
-25.3
-4702.0
·
-480.3
-500.8
-11996.5
-39409.6
-77400.9
·
EV / EBITDA
-0.4
-0.3
-8.7
-22.8
-5284.9
·
·
·
·
·
·
·
EV / FCF
-0.4
-0.2
-7.1
-25.3
-4699.8
·
·
·
·
·
·
·
EV / Revenue
17.2
18.7
·
601.9
69345.2
·
·
·
·
·
·
·
Earnings Yield
-230.3%
-308.1%
-870.4%
-4.5%
-0.40%
·
·
·
·
·
·
·
Gelir Tablosu15
IBIO için Çeyreklik Gelir Tablosu verileri
Metrik
Eğilim
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Revenue
$0
$0
$100.0K
$200.0K
$0
$200.0K
$0
$175.0K
$0
$0
$50.0K
$0
$0
$0
$0
$0
R&D Expense
$3M
$4M
$4M
$3M
$2M
$2M
$1M
$1M
$904.0K
$2M
$2M
$2M
$3M
$3M
$3M
$4M
SG&A Expense
$5M
$5M
$3M
$2M
$3M
$3M
$3M
$2M
$3M
$3M
$4M
$3M
$4M
$8M
$5M
$7M
Operating Expenses
$8M
$9M
$6M
$5M
$5M
$5M
$4M
$4M
$4M
$4M
$5M
$5M
$6M
$11M
$8M
$10M
Operating Income
$-8M
$-9M
$-6M
$-5M
$-5M
$-4M
$-4M
$-3M
$-4M
$-4M
$-5M
$-5M
$-6M
$-11M
$-8M
$-10M
Interest Expense
·
·
·
·
·
·
·
·
$52.0K
$34.0K
$26.0K
·
$35.0K
$31.0K
·
·
Interest Income
$657.0K
$493.0K
$267.0K
$79.0K
$72.0K
$112.0K
$174.0K
$223.0K
$43.0K
$42.0K
$55.0K
$50.0K
$23.0K
$41.0K
$99.0K
$66.0K
Other Non-op
$635.0K
$452.0K
$231.0K
$35.0K
$18.0K
$55.0K
$117.0K
$163.0K
$991.0K
$8.0K
$29.0K
$33.0K
$-110.0K
$10.0K
$99.0K
$68.0K
Income Tax
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Net Income
$-8M
$-9M
$-6M
$-5M
$-5M
$-4M
$-4M
$-8M
$-3M
$-8M
$-6M
$-6M
$-7M
$-34M
$-18M
$-17M
EPS (Basic)
$-0.06
$-0.09
$-0.11
$-0.32
$-0.49
$-0.48
$-0.46
$3.57
$-0.85
$-4.42
$-4.80
$-24.64
$-11.07
$-68.43
$-2.05
$-1.96
EPS (Diluted)
$-0.06
$-0.09
$-0.11
$-0.32
$-0.49
$-0.48
$-0.46
$3.57
$-0.85
$-4.42
$-4.80
$-24.64
$-11.07
$-68.43
$-2.05
$-0.59
Shares (Basic)
119,600,000
99,133,000
52,981,000
-17,128,000
9,862,000
9,132,000
8,633,000
-2,936,000
3,713,000
1,856,000
1,198,000
-9,379,000
659,000
490,000
8,842,000
-17,428,000
Shares (Diluted)
119,600,000
99,133,000
52,981,000
-17,128,000
9,862,000
9,132,000
8,633,000
-2,936,000
3,713,000
1,856,000
1,198,000
-9,379,000
659,000
490,000
8,842,000
-17,428,000
EBITDA
$-8M
$-9M
$-6M
·
$-5M
$-4M
$-4M
·
$-4M
$-4M
$-5M
·
$-6M
$-11M
$-8M
·
Bilanço23
IBIO için Çeyreklik Bilanço verileri
Metrik
Eğilim
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Cash & Equivalents
$48M
$29M
$28M
$9M
$5M
$7M
$11M
$14M
$5M
$3M
$1M
$4M
$7M
$4M
$10M
$23M
Receivables
·
·
$65.0K
·
·
·
·
·
·
·
$0
·
$70.0K
$970.0K
$1M
$1M
Inventory
·
·
·
·
·
·
·
·
$0
$0
$0
$0
·
·
·
$4M
Prepaid Expense
$2M
$670.0K
$1M
$1M
$1M
$1M
$667.0K
$749.0K
$862.0K
$894.0K
$451.0K
$664.0K
$921.0K
$414.0K
$1M
$2M
Current Assets
$77M
$53M
$51M
$10M
$6M
$8M
$12M
$16M
$36M
$20M
$23M
$26M
$27M
$38M
$64M
$45M
PP&E (Net)
$3M
$3M
$3M
$3M
$3M
$3M
$4M
$4M
$4M
$4M
$4M
$4M
$4M
$4M
$3M
$1M
PP&E (Gross)
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$4M
·
$1M
Accum. Depreciation
$2M
$2M
$2M
$1M
$1M
$1M
$1M
$1M
$893.0K
$729.0K
$565.0K
$400.0K
$235.0K
$115.0K
·
$0
Intangibles
$2M
$4M
$7M
$7M
$6M
$6M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$6M
$5M
Total Assets
$86M
$64M
$64M
$23M
$19M
$22M
$25M
$29M
$50M
$34M
$38M
$41M
$44M
$52M
$85M
$99M
Accounts Payable
$3M
$3M
$3M
$2M
$1M
$614.0K
$855.0K
$358.0K
$1M
$2M
$2M
$2M
$2M
$4M
$5M
$4M
Accrued Liabilities
$2M
$2M
$850.0K
$1M
$1M
$2M
$1M
$2M
$4M
$4M
$3M
$5M
$4M
$5M
$3M
$4M
Short-term Debt
·
·
$706.0K
$766.0K
$824.0K
$237.0K
$227.0K
$218.0K
$13M
$13M
$13M
·
$14M
$16M
$22M
$22M
Current Liabilities
$7M
$6M
$6M
$6M
$5M
$5M
$3M
$4M
$21M
$22M
$21M
$22M
$22M
$28M
$32M
$30M
Capital Leases
$2M
$2M
$2M
$2M
$2M
$2M
$3M
$3M
$3M
$3M
$3M
$3M
$3M
$3M
$3M
$4M
Total Liabilities
$8M
$8M
$8M
$8M
$8M
$8M
$7M
$7M
$25M
$25M
$24M
$26M
$27M
$33M
$36M
$36M
Total Debt
·
·
$706.0K
·
$824.0K
$237.0K
$227.0K
·
$13M
$13M
$13M
·
$14M
$16M
$22M
·
Common Stock
$35.0K
$30.0K
$20.0K
$19.0K
$10.0K
$9.0K
$9.0K
$9.0K
$9.0K
$30.0K
$28.0K
$1.0K
$16.0K
$12.0K
$9.0K
$9.0K
Retained Earnings
$-355M
$-347M
$-338M
$-332M
$-327M
$-322M
$-318M
$-314M
$-306M
$-303M
$-295M
$-289M
$-283M
$-276M
$-242M
$-224M
AOCI
$-21.0K
$10.0K
$-15.0K
·
·
·
·
·
·
·
·
·
·
$-167.0K
$-223.0K
$-213.0K
Stockholders' Equity
$78M
$57M
$56M
$15M
$11M
$14M
$18M
$21M
$25M
$9M
$13M
$15M
$17M
$19M
$48M
$63M
Liabilities + Equity
$86M
$64M
$64M
$23M
$19M
$22M
$25M
$29M
$50M
$34M
$38M
$41M
$44M
$52M
$85M
$99M
Shares Outstanding
34,543,561
30,053,070
20,254,599
19,349,201
10,066,276
9,167,670
8,637,895
8,623,676
8,517,449
3,243,725
27,653,582
1,015,505
12,368,287
12,368,287
9,006,582
8,727,158
Nakit Akışı10
IBIO için Çeyreklik Nakit Akışı verileri
Metrik
Eğilim
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Stock-based Comp
$377.0K
$253.0K
$323.0K
$270.0K
$370.0K
$475.0K
$415.0K
$360.0K
$457.0K
$456.0K
$765.0K
$446.0K
$2M
$1M
$1M
$1M
Amort. of Intangibles
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$49.0K
$67.0K
$68.0K
Operating Cash Flow
$-6M
$-5M
$-6M
$-5M
$-3M
$-4M
$-4M
$-5M
$-4M
$-5M
$-5M
$-5M
$-4M
$-8M
$-14M
$-12M
CapEx
$11.0K
$516.0K
$32.0K
$1.0K
$14.0K
$1.0K
$0
$210.0K
$0
·
·
$506.0K
$-201.0K
$3M
$2M
$3M
Investing Cash Flow
$-3M
$-3M
$-21M
$45.0K
$-14.0K
$-2.0K
$713.0K
$-144.0K
$1M
$0
$50.0K
$-6.0K
$8M
$-1M
$29.0K
$477.0K
Stock Issued
$3M
$0
$219.0K
$2M
$1M
$0
$4.0K
$14M
$4M
$4M
$3M
·
·
·
·
·
Net Stock Activity
·
·
$219.0K
·
·
·
$4.0K
·
·
·
·
·
·
·
·
·
Financing Cash Flow
$28M
$9M
$47M
$8M
$1M
$-152.0K
$-162.0K
$13M
$5M
$4M
$2M
$3M
$1M
$-3M
$1M
$-10.0K
Net Change in Cash
$19M
$561.0K
$20M
$4M
$-2M
$-4M
$-3M
$8M
$2M
$-701.0K
$-3M
$-2M
$6M
$-12M
$-13M
$-11M
Free Cash Flow
·
·
$-6M
·
·
·
·
·
·
·
·
·
·
·
$-16M
·
Kârlılık5
IBIO için Çeyreklik Kârlılık verileri
Metrik
Eğilim
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Operating Margin
·
·
-5951.0%
·
·
-2209.5%
·
·
·
·
-10206.0%
·
·
·
·
·
Net Margin
·
·
-5720.0%
·
·
-2182.0%
·
·
·
·
-11492.0%
·
·
·
·
·
EBITDA Margin
·
·
-5951.0%
·
·
-2209.5%
·
·
·
·
-10206.0%
·
·
·
·
·
ROA
-14.7%
-20.9%
-12.9%
·
-14.0%
-15.7%
-12.8%
·
-6.7%
-19.1%
-9.4%
·
-9.1%
-37.6%
-15.9%
·
ROE
-17.4%
-25.5%
-15.5%
·
-26.8%
-37.8%
-25.8%
·
-15.0%
-58.6%
-18.7%
·
-15.1%
-61.3%
-24.3%
·
Likidite ve Solventlik4
IBIO için Çeyreklik Likidite ve Solventlik verileri
Metrik
Eğilim
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Current Ratio
11.9
9.0
8.4
·
1.1
1.8
3.4
·
1.7
0.9
1.1
·
1.2
1.4
2.0
·
Quick Ratio
7.3
4.9
4.7
·
0.9
1.5
3.2
·
0.2
0.1
0.1
·
0.3
0.2
0.3
·
Debt / Equity
·
·
0.0
·
0.1
0.0
0.0
·
0.5
1.4
1.0
·
0.8
0.9
0.5
·
Interest Coverage
·
·
·
·
·
·
·
·
-69.7
-132.2
-196.3
·
-176.3
-341.1
·
·
Verimlilik2
IBIO için Çeyreklik Verimlilik verileri
Metrik
Eğilim
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Asset Turnover
·
0.0
0.0
·
0.0
0.0
0.0
·
·
·
0.0
·
0.0
0.0
0.0
·
Receivables Turnover
·
·
3.1
·
·
·
·
·
·
·
0.1
·
0.0
0.0
0.0
·
Hisse Başına5
IBIO için Çeyreklik Hisse Başına verileri
Metrik
Eğilim
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Book Value / Share
$2.24
$1.88
$2.77
·
$1.13
$1.52
$2.06
·
$2.92
$2.84
$0.48
·
$1.41
$1.52
$5.37
·
Revenue / Share
·
$0.00
$0.00
·
$0.00
$0.02
$0.00
·
·
·
$0.00
·
$0.00
$0.00
$0.00
·
Cash Flow / Share
·
·
$-0.11
·
·
·
$-0.43
·
·
·
$-0.22
·
·
·
$-1.58
·
Cash / Share
$1.38
$0.95
$1.39
·
$0.49
$0.77
$1.28
·
$0.62
$0.86
$0.05
·
$0.53
$0.30
$1.10
·
EPS (TTM)
$-0.75
$-1.17
$-1.54
·
$-2.28
$-6.21
$-10.53
·
$-21.14
$-88.72
$-86.35
·
$-82.97
$-73.27
$-7.24
·
Değerleme (TTM)14
IBIO için Çeyreklik Değerleme (TTM) verileri
Metrik
Eğilim
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Revenue TTM
$300.0K
$300.0K
$300.0K
·
·
·
·
·
$50.0K
$50.0K
$50.0K
·
$2M
$2M
$2M
·
Net Income TTM
$-27M
$-24M
$-19M
·
$-16M
$-20M
$-21M
·
$-24M
$-55M
$-65M
·
$-71M
$-76M
$-51M
·
Market Cap
$66M
$58M
$17M
·
$40M
$22M
$19M
·
$35M
$4M
$166M
·
$515M
$109M
$766M
·
Enterprise Value
·
·
$-11M
·
$36M
$16M
$8M
·
$42M
$14M
$177M
·
$522M
$121M
$778M
·
P/E
-2.5
-1.6
-0.5
·
-1.8
-0.4
-0.2
·
-0.2
-0.0
-0.1
·
-0.5
-0.1
-11.7
·
P/S
218.8
193.3
56.0
·
·
·
·
·
691.6
88.9
3318.4
·
285.8
60.5
406.3
·
P/B
0.8
1.0
0.3
·
3.6
1.6
1.1
·
1.4
0.5
12.6
·
29.6
5.8
15.8
·
P / Tangible Book
0.9
1.1
0.3
·
7.7
2.9
1.5
·
1.8
1.2
21.2
·
42.9
8.1
18.1
·
P / Cash Flow
·
·
-3.0
·
·
·
-5.2
·
·
·
-31.1
·
·
·
-54.8
·
P / FCF
·
·
-3.0
·
·
·
·
·
·
·
·
·
·
·
-46.6
·
EV / EBITDA
·
·
1.8
·
-7.4
-3.5
-2.0
·
-11.6
-3.2
-34.7
·
-84.6
-11.5
-101.9
·
EV / FCF
·
·
1.9
·
·
·
·
·
·
·
·
·
·
·
-47.3
·
EV / Revenue
·
·
-35.3
·
·
·
·
·
838.7
286.2
3541.7
·
289.8
67.3
412.9
·
Earnings Yield
-39.5%
-60.6%
-185.5%
·
-56.7%
-253.5%
-474.3%
·
-520.7%
-6475.9%
-1439.2%
·
-199.4%
-832.6%
-8.5%
·
Finansal Tablolar
Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
2025-06-30
2024-06-30
2023-06-30
2022-06-30
2021-06-30
Gelir
$400.0K
$225.0K
$0
$2M
$2M
Brüt Kâr Marjı %
—
—
—
90.9%
38.3%
Faaliyet Kâr Marjı %
-4650.5%
-7392.9%
—
-2085.2%
-1312.1%
Net Gelir
$-18M
$-25M
$-65M
$-50M
$-23M
Seyreltilmiş Hisse Başı Kâr
$-1.75
$-6.50
$-106.19
$-5.78
$-3.00
Bilanço
2025-06-30
2024-06-30
2023-06-30
2022-06-30
2021-06-30
Borç / Öz Sermaye
0.1
0.0
0.8
0.3
0.0
Cari Oran
1.6
4.1
1.2
1.5
15.7
Cari Oran
1.4
3.7
0.2
0.8
11.7
Nakit Akışı
2025-06-30
2024-06-30
2023-06-30
2022-06-30
2021-06-30
Serbest Nakit Akışı
$-15M
$-19M
$-36M
$-45M
$-35M
Metriklerim
Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F)
60 dosya · $59.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
Yeni pozisyonlar
Çıkan pozisyonlar
Artırıldı
Azaldı
Net hisse senedi değişimi
19
(+6 önceki Ç'ye göre)
12
(+1 önceki Ç'ye göre)
18
(+4 önceki Ç'ye göre)
9
(+1 önceki Ç'ye göre)
+16.7M
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler
5 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
Başvuru sahibi
Dosyalandı
Hisse
Durum
Amaç
Başvuru
EASTERN CAPITAL LIMITED, PORTFOLIO SERVICES LTD., KENNETH B. DART
×18 başvurular
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği
3 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.